RSS-Feed abonnieren

DOI: 10.5935/2526-8732.20200045
Oncological treatment in Brazil: a gender and region are associated to starting the therapeutics
Tratamento oncológico no Brasil: um risco associado ao início da terapêutica
Financial support: none to declare.

ABSTRACT
Introduction: Malignant neoplasms are a major public health problem, being the second leading cause of death in the world. In 2012, the Ministry of Health (BR) instituted Law No. 12,732, which grants cancer patients the right to obtain, from the anatomopathological diagnosis, access to the first treatment in the Brazilian Healthcare System - Sistema Único de Saúde (SUS), within up to sixty days. The change in the patient's prognosis is the aim of this program. Objective: To evaluate the panorama of the time to start cancer therapy in Brazil. Methods: This is a cross-sectional and analytical study on the time for the establishment of the beginning of cancer treatment in Brazil, in the period from 2013 to 2019. The data were extracted from the PANEL-Oncology of the informatics department of Unified Health System. Chi-square and Fisher's exact tests were used to analyze proportions and risk ratios, respectively. Results: The percentage of malignant neoplasms that had the longest delay in starting therapy (>60 days) in the country were prostate (59.6%) and cervix (50.9%). As for sex, the delay was present in 36.9% of men and 33.3% of women (p<0.05). Differences in the rates of cancers with and without delay for the institution of treatment are also evident in the Brazilian macroregions (p<0.05). Assessing the odds ratio for delayed cancer treatment, the male gender is shown to be a risk factor (p<0.05) in all regions, except in the North of the country. The risk for delayed treatment differs depending on the type of cancer. Conclusion: Cancers that have a longer delay in starting therapy are those that have health policies aimed at their screening.
RESUMO
Introdução: As neoplasias malignas são a segunda causa de mortes no mundo, configurando importante problema de saúde pública. Em 2012, o Ministério da Saúde (BR) instituiu a Lei nº 12.732, que concede ao paciente oncológico o direito de obter, a partir do diagnóstico anatomopatológico, o acesso ao primeiro tratamento no Sistema Único de Saúde (SUS), em até sessenta dias. A mudança no prognóstico do paciente é o objetivo deste programa. Objetivo: Avaliar o panorama do tempo para início da terapêutica oncológica no Brasil. Métodos: Trata-se de um estudo transversal e analítico sobre o tempo de implantação para o início do tratamento oncológico no Brasil, no período de 2013 a 2019. Os dados foram extraídos do PAINEL-Oncologia do departamento de informática do Sistema Único de Saúde. Os testes de qui-quadrado e exato de Fisher foram usados para analisar proporções e razões de risco, respectivamente. Resultados: As neoplasias malignas com maiores percentuais para o retardo (>60 dias) na instituição da terapêutica foram: próstata (59,6%) e colo do útero (50,9%). Quanto ao sexo, o atraso esteve presente em 36,9% dos homens e 33,3% das mulheres (p<0,05). Entre as macrorregiões brasileiras são evidenciadas diferenças relativas das taxas dos cânceres com e sem retardo no tempo para o início da terapêutica (p<0,05). Avaliando o odds ratio para retardo no tratamento do câncer, o sexo masculino se mostra como um fator de risco (p<0,05) em todas as regiões, exceto no norte do país. O risco de atraso no tratamento difere dependendo do tipo de câncer. Conclusão: Os cânceres que apresentam maior retardo no início da terapia são aqueles que possuem políticas de saúde voltadas ao seu rastreamento.
Publikationsverlauf
Eingereicht: 07. November 2020
Angenommen: 23. November 2020
Artikel online veröffentlicht:
18. Januar 2021
© 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
Isabelle Maria dos Anjos Chaves, Vitória Alice Alves de Oliveira, Davi Neri Araujo, Fernanda Freitas Lemos Lopes, Artur Trancoso Lopo de Queiroz, Maisa Almeida Silva, Alexandre Souza Queiroz, Lygia Accioly Tinoco, Kiyoshi Ferreira Fukutani. Oncological treatment in Brazil: a gender and region are associated to starting the therapeutics. Brazilian Journal of Oncology 2021; 17: e-20200045.
DOI: 10.5935/2526-8732.20200045
-
REFERENCES
-
Kumar V,
Abbas AK,
Aster JC..
Robbins & Cotran pathologic basis of disease. 9th. Rio de Janeiro: Elsevier;; 2015
MissingFormLabel
-
Ministério da Saúde (BR).
Secretaria de Atenção Especializada à Saúde. SAI/SUS - Sistema de Informações Ambulatoriais.
Oncologia. Manual de Bases Técnicas [Internet]. Brasília (DF): Ministério da Saúde;;
2016. Nov access in 2020 Sep 28 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/manual-oncologia-26a-edicao.pdf
MissingFormLabel
-
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).
Estimate/2020: cancer incidence in Brazil [Internet]. Rio de Janeiro (RJ): INCA; 2019.
access in 2020 Sep 28 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020incidencia-de-cancer-no-brasil.pdf
MissingFormLabel
-
Ministério da Saúde (BR).
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). A situação do câncer
no Brasil [Internet]. Rio de Janeiro (RJ): Rio de Janeiro: Ministério da Saúde/ INCA;
2006. access in 2020 Sep 28 Available from: https://bvsms.saude.gov.br/bvs/publicacoes/situacao_cancer_brasil.pdf
MissingFormLabel
-
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).
Duas décadas de dia mundial do câncer e “estimativa 2020” marcam o 4 de fevereiro
no INCA [Internet]. Rio de Janeiro (RJ): INCA; 2020. Jan access in 2020 Sep 28 Available
from: https://www.inca.gov.br/noticias/duas-decadas-de-diamundial-do-cancer-e-estimativa-2020-marcam-o4-de-fevereiro-no-inca#:~:text=Portugu%C3%AAs-,Duas%20d%C3%A9cadas%20de%20Dia%20Mundial%20do%20C%C3%A2ncer%20e%20%E2%80%9CEstimativa%202020,4%20
de%20Fevereiro%20no%20INCA&text=Em%20 2020%2C%20o%20Dia%20Mundial,Centro%20 do%20Rio%20de%20Janeiro
MissingFormLabel
-
DeNittis A,
Goldwein JW,
Dilling TJ..
The biology of cancer. . OncoLink Penn Medicine [Internet] 2002 May access in 2020
Sep 28 Available from: https://www.oncolink.org/healthcare-professionals/oncolinkuniversity/general-oncology-courses/an-introductionto-the-nature-of-cancer/the-biology-of-cancer
MissingFormLabel
-
OncoLink Penn Medicine.
An introduction to the nature of cancer - Cancer treatment. . OncoLink [Internet]
2002 May access in 2020 Sep 28 Available from: https://www.oncolink.org/cancer-treatment
MissingFormLabel
-
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).
Basic approaches to the cancer control [Internet]. 4th. Rio de Janeiro (RJ): INCA;;
2012. access in 2020 Oct 4 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/livro-abc-4-edicao.pdf
MissingFormLabel
-
Ordinance No. 874, 2013 May 16 (BR).
Institutes the national policy for the prevention and control of cancer in the health
care network of people with chronic diseases within the scope of the Sistema Único
de Saúde (SUS) [Internet]. Brasília (DF): Ministry of Health; access in 2020 Sep 28
Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0874_16_05_2013.html
MissingFormLabel
-
Ordinance No. 876, 2013 May 16 (BR).
Requirements on the application of Law No. 12,732, of November 222012, which deals
with the first treatment of patients with proven malignancy, within the scope of the
Sistema Único de Saúde (SUS) [Internet]. Brasília (DF): Ministry of Health;; 2016.
access in 2020 Sep 28 Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0876_16_05_2013.html
MissingFormLabel
-
Law No. 12,732, 2012 November 22 (BR).
Provides for the first treatment of a patient with proven malignancy and establishes
a deadline for its beginning. . Official Gazette 23 Nov; 2012 access in 2020 Sep 28.
Available from: http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12732.htm
MissingFormLabel
-
IQVIA™.
Cancer in Brazil: the patient's journey in the health system and its social and financial
impacts [Internet]. Danbury: IQVIA;; 2016. [cited 2020 Sep 29]; Available from: https://www.interfarma.org.br/public/files/biblioteca/cancer-no-brasil-n-ajornada-do-paciente-no-sistema-de-saude-e-seusimpactos-sociais-e-financeiros-interfarma.pdf
MissingFormLabel
-
Xavier DC,
Oliveira RAD,
Matos VP,
Viacava F,
Carvalho CC..
Mammograms coverage, allocation and use of equipment in the Health Regions. Saúde
Debate [Internet] 2016; [Sep cited 2020 Sep 30]; 40 (110) 20-35 Available from: https://www.scielo.br/pdf/sdeb/v40n110/0103-1104-sdeb-40-110-0020.pdf
MissingFormLabel
-
Kaliks RA,
Matos TF,
Silva VA,
Barros LHC..
Differences in systemic cancer treatment in Brazil: my Public Health System is different
from your Public Health System. Braz J Oncol [Internet] 2017; [Jun cited 2020 Sep
29]; 13 (44) 1-12 Available from: https://cdn.publisher.gn1.link/brazilianjournalofoncology.com.br/pdf/v13n44a05.pdf
MissingFormLabel
-
Felippu AWD,
Freire EC,
Silva RA,
Guimarães AV,
Dedivitis RA..
Impact of delay in the diagnosis and treatment of head and neck cancer. Braz J Otorhinolaryngol
2016; Feb; 82 (03) 140-143
MissingFormLabel
-
Silva ICM,
Restrepo-Mendez MC,
Costa JC,
Ewerling F,
Hellwig F,
Ferreira LZ.
et al
Measurement of social inequalities in health: concept sand methodological approaches
in the Brazilian context. Epidemiol Serv Saúde 2018; Mar; 27 (01) e000100017 https://doi.org/10.5123/s1679-49742018000100017
MissingFormLabel
-
Barata RB..
How and why social inequalities harm health [Internet]. Rio de Janeiro (RJ): Ed. FIOCRUZ;
2009. access in 2020 Sep 29 Available from: https://static.scielo.org/scielobooks/48z26/pdf/barata-9788575413913.pdf
MissingFormLabel
-
Pitombeira DF,
Oliveira LC..
Poverty and social inequality: tensions between rights and austerity and its implications
for primary healthcare. Ciênc Saúde Coletiva 2020; May; 25 (05) 1699-1708 http://dx.doi.org/10.1590/1413-81232020255.33972019
MissingFormLabel
-
Kaliks RA,
Matos TF,
Silva VA,
Barros LHC..
Differences in systemic cancer treatment in Brazil: my Public Health System is different
from your Public Health System. Braz J Oncol [Internet] 2017; [Jun cited 2020 Sep
30]; 13 (44) 1-12 Available from: https://cdn.publisher.gn1.link/brazilianjournalofoncology.com.br/pdf/v13n44a05.pdf ref. é igual a n. 14
MissingFormLabel
-
Teixeira LA,
Porto M,
Habib BABB..
Public policies for cancer control in Brazil: elements of a trajectory. Cad Saúde
Coletiva [Internet] 2012; [cited 2020 Sep 29]; 20 (03) 375-380 Available from: https://www.arca.fiocruz.br/handle/icict/23906
MissingFormLabel
-
Gadelha MIP..
30 years of cancer care in the Brazilian National Health System. Rev Bras Cancerol
[Internet] 2018; Jun; 64 (02) 237-245 https://doi.org/10.32635/2176-9745.RBC.2018v64n2.83
MissingFormLabel
-
Silva MJS,
Lima FLT,
O'Dwyer G,
Osorio-de-Castro CGS..
Cancer care policy in Brazil after creation of Unified Health System. Rev Bras Cancerol
[Internet] 2017; [Jan cited 2020 Sep 29]; 63 (03) 1778 Available from: https://rbc.inca.gov.br/revista/index.php/revista/article/view/133/71
MissingFormLabel
-
Ministério da Saúde (BR).
Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Caderno de Atenção
Primária - Rastreamento. In: Ministério da Saúde, ed. Detecção precoce de câncer
[Internet]. 29th. Brasília (DF): Ministério da Saúde;; 2010. access in 2020 Sep 29
67-79 Available from: http://bvsms.saude.gov.br/bvs/publicacoes/caderno_atencao_primaria_29_rastreamento.pdf
MissingFormLabel
-
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).
Guidelines for the early detection of breast cancer in Brazil [Internet]. Rio de Janeiro
(RJ): INCA; 2015. access in 2020 Sep 29 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//diretrizes_deteccao_precoce_cancer_mama_brasil.pdf
MissingFormLabel
-
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA).
Brazilian cervical cancer screening guidelines [Internet]. 2nd. Rio de Janeiro (RJ):
INCA;; 2016. access in 2020 Sep 29 Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/diretrizesparaorastreamentodocancerdocolodoutero_2016_corrigido.pdf
MissingFormLabel
-
Rodrigues JD,
Cruz MS,
Paixão AN..
An analysis of breast cancer prevention in Brazil. Ciênc Saúde Coletiva [Internet]
2015; [Jul cited 2020 Sep 29]; 20 (10) 3163-3176 Available from: https://www.scielo.br/pdf/csc/v20n10/1413-8123-csc-20-10-3163.pdf
MissingFormLabel
-
Sociedade Brasileira de Patologia Clínica/Medicina Laboral (SBPC/ML).
Sociedade Brasileira de Urologia (SBU). Posicionamento da SBPC/ML e SBU sobre rastreio
de câncer de próstata. Rio de Janeiro (RJ): SBPC/SBU;; 2018. Nov access in 2020 Sep
30 Available from: http://www.sbpc.org.br/noticias-ecomunicacao/posicionamento-da-sbpcml-e-sbusobre-rastreio-de-cancer-de-prostata/
MissingFormLabel
-
Steffen RE,
Trajman A,
Santos M,
Caetano R..
Population screening for cancer prostate cancer: more risks than benefits. Physis
2018; Mar.; 28 (02) e280209 http://dx.doi.org/10.1590/S0103-73312018280209
MissingFormLabel
-
Alves CM,
Bastos RR,
Guerra MR..
Mortality due to cancer of the uterine cervix in the state of Minas Gerais, Brazil,
1980- 2005: period and cohort analysis. Cad Saúde Pública [Internet] 2010; [Jul cited
2020 Oct 04]; 26 (07) 1446-1456 Available from: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102311X2010000700024
MissingFormLabel
-
Santana PM..
Retardo do tratamento de mulheres com câncer do colo do útero. [dissertation] Salvador
(BA): FIOCRUZ; 2016. access in 2020 Oct 04 Available from: https://www.arca.fiocruz.br/bitstream/icict/18010/2/Perla%20Machado%20Santana.%20Retardo%20do%20tratamento...2016.pdf
MissingFormLabel
-
Löwy I..
Cancer, women, and public health: the history of screening for cervical cancer. Hist
Ciênc SaúdeManguinhos [Internet] 2010; [Jul cited 2020 Oct 04]; 17 (Suppl 1): 53-67
Available from: https://www.scielo.br/pdf/hcsm/v17s1/04.pdf
MissingFormLabel
-
Barbosa IR,
Souza DLB,
Bernal MM,
Costa ICC..
Regional inequalities in cervical cancer mortality in Brazil: trends and projections
through to 2030. Ciênc Saúde Coletiva [Internet] 2016; [Jan cited 2020 Oct 04]; 21
(01) 253-262 Available from: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232016000100253
MissingFormLabel
-
Souto R..
The human papillomavirus: a factor related with the formation of neoplasias. Rev Bras
Cancerol [Internet] 2005; [May cited 2020 Oct 04]; 51 (02) 15560 Available from:
https://rbc.inca.gov.br/site/arquivos/n_51/v02/pdf/revisao2.pdf
MissingFormLabel
-
Mutschall L,
França PC,
Ferreira LE,
Fronza JR H,
Blasios R,
Pinho M..
Analysis of Relationship Between VEGF Protein Expression and Colorectal Câncer Staging.
Rev bras Coloproct [Internet] 2009; [cited 2020 Oct 2]; 29 (01) 15-22 Available from:
http://sbcp.org.br/revista/nbr291/p15_22.htm
MissingFormLabel
-
Assis RVBF..
Tracking and surveillance of colorectal: guidelines world. GED Gastroenterol Endosc
Dig [Internet] 2011; [Jan cited 2020 Oct 04]; 30 (02) 62-74 Available from: http://files.bvs.br/upload/S/0101-7772/2011/v30n2/a2916.pdf
MissingFormLabel
-
Araujo LH,
Baldotto C,
Castro Junior G,
Katz A,
Ferreira CG,
Mathias C.
et al
Câncer de pulmão no Brasil. J Bras Pneumol [Internet] 2018; [Jan cited 2020 Oct 22];
44 (01) 55-64 Available from: https://www.scielo.br/pdf/jbpneu/v44n1/pt_18063713-jbpneu-44-01-00055.pdf
MissingFormLabel